Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials
Reflects Global COVID-19 Trial Recruitment Challenge
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.

GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.